176 related articles for article (PubMed ID: 24593233)
21. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
[TBL] [Abstract][Full Text] [Related]
22. Mitotic rate is a more reliable unfavorable prognosticator than ulceration for early cutaneous melanoma: a 5-year survival analysis.
Donizy P; Kaczorowski M; Leskiewicz M; Zietek M; Pieniazek M; Kozyra C; Halon A; Matkowski R
Oncol Rep; 2014 Dec; 32(6):2735-43. PubMed ID: 25310673
[TBL] [Abstract][Full Text] [Related]
23. The importance of mitosis as a factor for predicting sentinel lymph node biopsy for thin melanoma.
Oliveira Filho RS; Jorge MC; Oliveira DA; Oliveira RL; Queiroz Mdo C; Nahas FX
An Bras Dermatol; 2011; 86(4 Suppl 1):S107-9. PubMed ID: 22068786
[TBL] [Abstract][Full Text] [Related]
24. How does the mitotic index impact patients with T1 melanoma? Comparison between the 7th and 8th edition of the American Joint Committee on Cancer melanoma staging system.
Antonialli AZ; Bertolli E; de Macedo MP; Pinto CAL; Calsavara VF; Neto JPD
An Bras Dermatol; 2020; 95(6):691-695. PubMed ID: 33008658
[TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
26. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM
Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331
[TBL] [Abstract][Full Text] [Related]
27. Clinical and prognostic factors for melanoma of the skin using SEER registries: collaborative stage data collection system, version 1 and version 2.
Kosary CL; Altekruse SF; Ruhl J; Lee R; Dickie L
Cancer; 2014 Dec; 120 Suppl 23():3807-14. PubMed ID: 25412392
[TBL] [Abstract][Full Text] [Related]
28. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
29. A population-based validation of the American Joint Committee on Cancer melanoma staging system.
Gimotty PA; Botbyl J; Soong SJ; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8065-75. PubMed ID: 16258105
[TBL] [Abstract][Full Text] [Related]
30. Inter-observer variation in the histopathology reports of head and neck melanoma; a comparison between the seventh and eighth edition of the AJCC staging system.
Berger DMS; Wassenberg RM; Jóźwiak K; van de Wiel BA; Balm AJM; van den Berg JG; Klop WMC
Eur J Surg Oncol; 2019 Feb; 45(2):235-241. PubMed ID: 30385156
[TBL] [Abstract][Full Text] [Related]
31. The magic of numbers: malignant melanoma between science and pseudoscience.
Weyers W
Am J Dermatopathol; 2011 Jun; 33(4):371-8. PubMed ID: 21478727
[TBL] [Abstract][Full Text] [Related]
32. Melanoma staging: where are we now?
Piris A; Lobo AC; Duncan LM
Dermatol Clin; 2012 Oct; 30(4):581-92, v. PubMed ID: 23021047
[TBL] [Abstract][Full Text] [Related]
33. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
34. A novel and accurate computer model of melanoma prognosis for patients staged by sentinel lymph node biopsy: comparison with the American Joint Committee on Cancer model.
Callender GG; Gershenwald JE; Egger ME; Scoggins CR; Martin RC; Schacherer CW; Edwards MJ; Urist MM; Ross MI; Stromberg AJ; McMasters KM
J Am Coll Surg; 2012 Apr; 214(4):608-17; discussion 617-9. PubMed ID: 22342785
[TBL] [Abstract][Full Text] [Related]
35. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
Paek SC; Griffith KA; Johnson TM; Sondak VK; Wong SL; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
Cancer; 2007 Jan; 109(1):100-8. PubMed ID: 17146784
[TBL] [Abstract][Full Text] [Related]
36. AJCC melanoma staging update: impact on dermatopathology practice and patient management.
Piris A; Mihm MC; Duncan LM
J Cutan Pathol; 2011 May; 38(5):394-400. PubMed ID: 21385199
[TBL] [Abstract][Full Text] [Related]
37. How pathologic staging informs the surgical management of primary cutaneous melanoma.
Tsai S; Balch CM
G Ital Dermatol Venereol; 2010 Apr; 145(2):187-93. PubMed ID: 20467392
[TBL] [Abstract][Full Text] [Related]
38. Melanoma staging and sentinel lymph node biopsy.
Forsea AM
Acta Dermatovenerol Croat; 2010; 18(4):279-88. PubMed ID: 21251448
[TBL] [Abstract][Full Text] [Related]
39. Malignant melanoma of the vulva: an extension of cutaneous melanoma?
Moxley KM; Fader AN; Rose PG; Case AS; Mutch DG; Berry E; Schink JC; Kim CH; Chi DS; Moore KN
Gynecol Oncol; 2011 Sep; 122(3):612-7. PubMed ID: 21570710
[TBL] [Abstract][Full Text] [Related]
40. Morphologic Forms and Classification of Dermal Mitotic Figure Density in Primary Cutaneous Melanoma: A Retrospective Study.
Marsch AF; McKee RM; Hinds BR
Am J Dermatopathol; 2020 Jan; 42(1):35-40. PubMed ID: 31884499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
